H Shelton Earp, Iii

Title: H Shelton Earp, III: Innovator in Cancer Treatment

Introduction

H Shelton Earp, III is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, Earp has focused on developing methods that enhance therapeutic options for cancer patients.

Latest Patents

Earp's latest patents include a method of treating cancer with a combination of a MER tyrosine kinase inhibitor and an epidermal growth factor receptor (EGFR) inhibitor. This invention provides combinations comprising a MERTK inhibitor, or a pharmaceutically acceptable salt thereof, and an EGFR inhibitor, along with methods of use for treating disorders such as cancer. Another significant patent is for isolated DNA encoding the c-mer protooncogene. This patent discloses isolated DNAs encoding a mammalian c-mer receptor that exhibits c-mer protooncogene activity and tyrosine kinase activity. It also includes vectors containing such DNAs, host cells, c-mer receptor proteins, and antibodies that specifically bind the c-mer receptor.

Career Highlights

Earp has had a distinguished career, working at prestigious institutions such as the University of North Carolina at Chapel Hill and Emory University. His work has been instrumental in advancing the understanding and treatment of cancer.

Collaborations

Throughout his career, Earp has collaborated with notable colleagues, including Doug Graham and Thomas L Dawson. These collaborations have further enriched his research and contributed to the development of his patented inventions.

Conclusion

H Shelton Earp, III is a prominent figure in the field of cancer research and treatment. His innovative patents and collaborations have made a lasting impact on the medical community. His work continues to inspire advancements in cancer therapies and improve patient outcomes.